YPYann Péréon

Yann Péréon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yann Péréon has a total of 480 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder

    by Lucas Pacoureau, Louise Bicart-Sée, Le Guen Morgane, Karine Viala, Thierry Maisonobe, Guillemette Beaudonnet, Clovis Adam, Alex Vicino, Marie Théaudin, David Boutboul, et al.

    Background and ObjectivesPeripheral neuropathies (PNs) associated with T-cell lymphoproliferative disorders (T-Ly) are exceptionally rare and poorly characterized. Whether their mechanisms, clinica...

  • Bernard was right about the placenta

    by Emmanuel Drouin, Yann Péréon

  • Historical and Clinical Analysis of a Case of Progressive Muscular Atrophy (1853–1871)

    by Emmanuel Drouin, Yann Pereon

    Background: Progressive muscular atrophy (PMA) emerged in the mid-19th century as a distinct clinical entity within the evolving field of French neurology, notably through the work of François Amilcar Aran, Duchenne de Boulogne, and later Jean-Martin Charcot. During this period, uncertainties persisted regarding its nosological status, pathophysiology, and relationship to amyotrophic lateral sclerosis (ALS). Longitudinal clinical observations from this era remain rare but are essential for understanding both the natural history of motor neuron diseases and the historical construction of neurological knowledge. Summary: This article presents a historical and clinical analysis of a unique case of PMA observed for over nearly 2 decades (1853–1871) in Parisian hospitals. The case concerns Auguste-Joseph Bellinghen, whose condition was first documented in an unpublished handwritten manuscript in 1853 and later published with photographic illustrations in 1871. Through a comparative analysis of these two observations, the study traces the slow, asymmetrical, and irreversible progression of muscular atrophy, marked by early fasciculations, the absence of sensory disturbances, and eventual severe motor disability. The case is examined within its institutional, nosological, and therapeutic contexts, highlighting hospital circulation, the role of medical interns, and the empirical treatments of the time, including electrotherapy and thermal baths. Reinterpreted in light of contemporary neurology, this historical observation likely corresponds to a spinal-onset motor neuron disease closely related to ALS. Beyond its clinical significance, the case illustrates the transition from descriptive clinical medicine to anatomoclinical correlation and contributes to the historiography of neurology by illuminating how individual patient trajectories shaped medical knowledge in the 19th century. Key Messages: (1) Long-term historical clinical observations provide valuable insights into the natural history of PMA and motor neuron diseases. (2) The Bellinghen case illustrates the evolution of neurological semiology, particularly the early recognition of fasciculations and asymmetrical muscle wasting. (3) This case highlights the transition from Aran’s initial clinical description of PMA to Charcot’s anatomopathological framework linking PMA to ALS. (4) Historical medical archives offer not only scientific data but also a window into the social consequences of chronic neurological disease in the 19th century. (5) Integrating historical and clinical analysis enriches contemporary understanding of motor neuron disease nosology and medical memory.

  • Open Access

    Active-NDM: Development of a patient-reported outcome questionnaire to measure the impact of non-dystrophic myotonia on activity of daily living

    by Ahmed Amara, Michele Cavalli, Andra Ezaru, Angela Puma, Jérémy Garcia, Sophie Meiran, Aurora Parrotta, Savine Vicart, Yann Péréon, Emmanuelle Salort-Campana, et al.

    Background: There is a considerable challenge in managing non-dystrophic myotonias (NDM), due to the lack of gold-standard outcome measures to assess NDM burden on activities of daily living and quality of life from the patient's perspective. Objective: In this study, we aim to develop and validate a specific NDM patient-reported outcome (PRO) questionnaire. Methods: The Active-NDM questionnaire was developed through a modified 2-round Delphi procedure integrating feedback from stakeholders and a systematic literature review, with input from 11 national clinical experts. The questionnaire was validated in a pilot study of 10 patients with NDM. Both clinical experts and patients assessed questions for pertinence/relevance and clarity. We excluded questions that were not considered pertinent/relevant, and reformulated any judged to be poorly formulated, by >80% of the experts/patients. We also excluded questions with <80% reproducibility during the pilot study. Results: Based on feedback from experts and findings of the systematic literature review, we identified 130 questions, of which 100 were unduplicated. During the Delphi process, we removed 66 questions due to lack of pertinence and/or relevance. In the pilot study, patients with NDM evaluated the resulting 34-questions for pertinence, clarity, and reproducibility. Subsequently we removed 9 questions that did not achieve the required level of reproducibility. Conclusion: We developed the Active-NDM questionnaire, composed by 25 questions, figuring as a new NDM-specific measure to determine the impact of the disease on patients’ activities of daily living and quality of life. Active-NDM could be a valuable tool in the management of patients with NDM. These findings should be interpreted as preliminary. Larger-scale validation studies are warranted to confirm the tool's psychometric properties and generalizability. ClinicalTrials.gov identifier: NCT06136416

  • Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies

    by Ricardo J. Andrade, Antoine Nordez, Armelle Magot, Laura Couloume, Jean‐Philippe Plançon, Jean‐Baptiste Quillard, Robert S. Ware, Michel W. Coppieters, Yann Péréon, François Hug

    Background and Aims: Repeated cycles of demyelination and remyelination alter nerve tissue composition, likely affecting its material properties, including stiffness. Using ultrasound shear wave elastography (SWE), we assessed nerve shear wave velocity (SWV), a surrogate measure of stiffness, to determine its potential as a biomarker for demyelinating neuropathies, including chronic inflammatory demyelinating polyneuropathy, Charcot‐Marie‐Tooth type 1A, and anti‐myelin‐associated glycoprotein neuropathy.Methods: This cross‐sectional study compared nerve SWV between 20 patients with demyelinating neuropathies (60.2 ± 13.1 years) and 16 age‐matched controls (56.8 ± 10.8 years). Each participant underwent bilateral SWE of the proximal and distal segments of four peripheral nerves in the upper (median, ulnar and radial) and lower (sciatic‐tibial) limbs. Measurements were conducted in different limb positions to mimic two nerve tensile states, yielding a total of 32 nerve stiffness measurements per participant. Conventional nerve cross‐sectional area was further evaluated for each nerve and location.Results: Individuals with demyelinating polyneuropathy exhibited increased nerve SWV compared to age‐matched controls (mean difference = 0.7 m/s, 95%CI [0.5 to 0.9]; p < 0.0001). This difference was observed across all nerves and regions, with the largest difference noted in the tibial. Axial nerve tension amplified these differences. Additionally, moderate to high negative correlations were observed between motor nerve conduction and nerve SWV.Interpretation: This study identifies significant neuropathy‐associated alterations in peripheral nerve elasticity. Our findings suggest that nerve stiffness could be a promising biomarker for demyelinating neuropathies, and provide a basis for the development of standardized peripheral nerve SWE protocols.


  • Guillain-Barré syndrome in patients with Charcot-Marie-Tooth type 1A disease, probably a non-random association

    by Jean-Baptiste Davion, Jérôme Devaux, Céline Tard, Armelle Magot, François Cassim, Yann Péréon


  • The Origins of Neuromuscular Electrodiagnosis, 1800–1950: A Crucial Period

    by Laurent Tatu, Yann Péréon

    The two components of today's electroneuromyography (i.e. neurography and myography) gradually emerged from the harmful practice of electrotherapy during the crucial period of 1800-1950. At the beginning of the 19th century, galvanism was supplemented by the fashionable induction coils created by Heinrich Daniel Ruhmkorff (1803-1877). In the same decades, major physiological research was performed by the Italian Carlo Matteuci (1811-1868), the Germans Emil Heinrich du Bois Reymond (1818-1896) and Eduard Pflüger (1829-1910) and the French Claude Bernard (1813-1878). This led to the description of the nerve action potential and to the measurement of the speed of nerve impulses in frogs by Hermann von Helmholtz (1821-1894). In the mid-19th century, Guillaume Duchenne de Boulogne (1806-1875) designed his own electrical equipment to perform faradisation, a focal electrification using induction current. Duchenne's methodology and conclusions led to a heated debate with Robert Remak (1815-1865) about the use of galvanic current, and with Hugo von Ziemssen (1829-1902) about the points which were to become the motor point. In the following years, the galvanic polar method was developed. Rudolf Brenner (1821-1884) formalised a literal notation of this method, expressing the muscle contraction formula by a system of letters. From the 1880s, a standardisation of electrodiagnostic exploration began. The German neurologist Wilhelm Erb (1840-1921) formalised a more complex situation called Entartungsreaktion (degenerative reaction). During WW1, a bipolar method was used and André Strohl (1887-1977) performed the electrical recording of tendon reflexes. Myography emerged in the first years of the 20th century thanks to the physiological work of Keith Lucas (1879-1916) and Charles Sherrington (1857-1952). The concentric needle, designed by Edgar Adrian (1889-1977) and Detlev Bronk (1807-1975), and the development of the cathode-ray oscilloscope were of great interest for electromyography. Such oscilloscopes also allowed Joseph Erlanger (1874-1965) and Herbert Gasser (1888-1963) to graph the action potential of a frog's sciatic nerve. During WW2, the American James G. Golseth (1912-2003) and James A. Fizzell (1912-1995) worked with the Canadian Herbert H. Jasper (1906-1999). They demonstrated the importance of interpreting myography and neurography together. In England, Herbert Seddon (1903-1977) and Graham Weddell (1908-1990) described the evolution of nerve injuries and muscle denervation on wounded soldiers. In the 1950s, the first widespread marketing of electromyographic devices allowed a new generation of neurologists to be invested in this novel topic.